These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 4714228)

  • 1. Interactions of the hexobarbital enantiomers with rat liver microsomes.
    Feller DR; Lubawy WC
    Pharmacology; 1973; 9(3):129-37. PubMed ID: 4714228
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of dietary protein quality on drug metabolism in the rat.
    Miranda CL; Webb RE
    J Nutr; 1973 Oct; 103(10):1425-30. PubMed ID: 4745519
    [No Abstract]   [Full Text] [Related]  

  • 3. Kinetic parameters of drug-metabolizing enzymes in Ca 2+ -sedimented microsomes from rat liver.
    Cinti DL; Moldeus P; Schenkman JB
    Biochem Pharmacol; 1972 Dec; 21(24):3249-56. PubMed ID: 4405367
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of puromycin on binding and on metabolism in vitro of substrates by rat liver microsomes.
    Soliman MR; Wade AE
    Biochem Pharmacol; 1972 Oct; 21(19):2652-6. PubMed ID: 4661623
    [No Abstract]   [Full Text] [Related]  

  • 5. The binding of hexobarbital and aniline to cytochrome P-450 of liver microsomes from control and phenobarbital-treated rats of different ages.
    Müller D; Klinger W
    Acta Biol Med Ger; 1976; 35(5):627-33. PubMed ID: 983613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective hydroxylation of hexobarbital enantiomers by rat liver microsomes.
    Miyano K; Fujii Y; Toki S
    Drug Metab Dispos; 1980; 8(2):104-10. PubMed ID: 6103782
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of malathion on hepatic microsomal metabolism of the male mouse.
    Stevens JT
    Pharmacology; 1974; 11(6):330-5. PubMed ID: 4413070
    [No Abstract]   [Full Text] [Related]  

  • 8. Decreased effect of phenobarbital treatment on microsomal drug metabolizing enzyme activity during gestation.
    Schlede E; Borowski R
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 281(4):341-55. PubMed ID: 4275256
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of spironolactone on drug metabolism by hepatic microsomes.
    Stripp B; Hamrick ME; Zampaglione NG; Gillette JR
    J Pharmacol Exp Ther; 1971 Mar; 176(3):766-71. PubMed ID: 5111461
    [No Abstract]   [Full Text] [Related]  

  • 10. Interactions of spironolactone with hepatic microsomal drug-metabolizing enzyme systems.
    Feller DR; Gerald MC
    Biochem Pharmacol; 1971 Aug; 20(8):1991-2000. PubMed ID: 4400282
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of phenobarbital or pregnenolone-16alpha-carbonitrile (PCN) pretreatment on acute carbon tetrachloride hepatotoxicity in rats.
    Tuchweber B; Werringloer J; Kourounakis P
    Biochem Pharmacol; 1974 Feb; 23(3):513-8. PubMed ID: 4362747
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of suramin (Bayer 205) on hepatic microsomal cytochromes P-450, b 5 , and demethylation activity in rats.
    Basu TK; Stewart PS; Harris RG; Williams DC
    Biochem Pharmacol; 1973 Apr; 22(8):987-9. PubMed ID: 4693831
    [No Abstract]   [Full Text] [Related]  

  • 13. Species differences in the effect of morphine administration or adrenalectomy on the substrate interactions with cytochrome P-450 and drug oxidations by liver microsomes.
    Kato R; Onoda KI; Takanaka A
    Biochem Pharmacol; 1971 Jun; 20(6):1093-9. PubMed ID: 5118111
    [No Abstract]   [Full Text] [Related]  

  • 14. Active centers of microsomal cytochrome P-450 determined with metyrapone by mutural depletion system kinetics.
    Roots I; Hildebrandt AG
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(1):39-52. PubMed ID: 4267597
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of active centers of hepatic microsomal cytochrome P-450 by metyrapone, applying mutual depletion system kinetics.
    Roots I; Hildebrandt AG
    Drug Metab Dispos; 1973; 1(1):194-8. PubMed ID: 4149383
    [No Abstract]   [Full Text] [Related]  

  • 16. Disulfiram impairment of drug metabolism by rat liver microsomes.
    Stripp B; Greene FE; Gillette JR
    J Pharmacol Exp Ther; 1969 Dec; 170(2):347-54. PubMed ID: 4391007
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the effects of methylmercury on ethylmorphine N-demethylase and aniline hydroxylase activities and on the conversion of cytochrome P-450 to cytochrome P-420.
    Alvares AP; Cohn J; Kappas A
    Drug Metab Dispos; 1974; 2(3):259-66. PubMed ID: 4153087
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence for an inhibitory product-cytochrome P-450 complex generated during benzphetamine metabolism by liver microsomes.
    Werringloer J; Estabrook RW
    Life Sci; 1973 Nov; 13(10):1319-30. PubMed ID: 4148650
    [No Abstract]   [Full Text] [Related]  

  • 19. Calculation of competitive inhibition of substrate binding to cytochrome P-450 illustrated by the interaction of d,l-propranolol with d,l-hexobarbital.
    Bast A; Noordhoek J
    Biochem Pharmacol; 1980 Mar; 29(5):747-51. PubMed ID: 20227951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heme enhances hexobarbital metabolism in perfused rat liver after drug-mediated destruction of cytochrome P-450.
    Farrell GC; Gollan JL; Correia MA; Schmid R
    J Pharmacol Exp Ther; 1981 Aug; 218(2):363-7. PubMed ID: 7252836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.